Skip to main content

Anna Meseguer Navarro

Institutions of which they are part

Main researcher
Kidney Physiopathology
Vall Hebron Institut de Recerca

Anna Meseguer Navarro

Institutions of which they are part

Main researcher
Kidney Physiopathology
Vall Hebron Institut de Recerca

Projects

Implicación de la ciclofilina B (CYBP) y de las proteínas que con ella interaccionan, en el daño renal agudo

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin
Funding agency: Fundación Renal Iñigo Alvarez de Toledo
Funding: 18000
Reference: FRIAT_01_2007
Duration: 01/01/2008 - 31/12/2009

Mecanismos moleculares implicados en la nefrotoxicidad producida por Ciclosporina A (CsA) y FK506 en el túbulo proximal renal.

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin
Funding agency: Instituto de Salud Carlos III
Funding: 154675
Reference: PI020829
Duration: 06/11/2002 - 06/11/2005

Implicacions del receptor del virus de l'hepatitis A humà (hHAVcr-1) en el desenvolupament i la progressió del carcinoma renal. Valor com a marcador diagnòstic i pronòstic en els carcinomes de bufeta i renals

IP: Anna Meseguer Navarro
Collaborators: Santiago Ramon y Cajal Agüeras, Joan Morote Robles, Enric Trilla Herrera
Funding agency: Fundació La Marató de TV3
Funding: 204625
Reference: TV3/052410
Duration: 01/01/2006 - 30/04/2010

Las ciclofilinas en el fracaso renal agudo tóxico. Identificación de biomarcadores pronósticos y de posibles dianas terapéuticas.

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 38200
Reference: FMMA/01/2005
Duration: 11/09/2006 - 10/09/2009

Related news

The team has discovered that a protein called SEC22B acts as a phenotype modifier and could be used as a potential urinary marker of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The aim of the project is to establish kidney organoids derived from patients with familial hypomagnesaemia with hypercalciuria and nephrocalcinosis, which will be essential tools for studying the disease and testing new treatments.

Related professionals

PATRICIA LAUNOIS OBREGÓN

PATRICIA LAUNOIS OBREGÓN

Predoctoral researcher
Physical Medicine and Rehabilitation
Read more
Gianluca Pellino

Gianluca Pellino

Main researcher
General Surgery
Read more
Cristina Gamez Cenzano

Cristina Gamez Cenzano

Senior researcher
Molecular Imaging and Therapy
Read more
Ana Belén  Méndez Fernández

Ana Belén Méndez Fernández

Main researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.